CoverageForm 410-K10-Q8-K13D13G13F

Mymd Pharmaceuticals, Inc.

MYMDCIK 0001321834 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback
Full filing:tone -0.0034

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Mymd Pharmaceuticals, Inc.

NameRolesFilings
Rivard Paul
Officer
3
Voss Chelsea Sierra
Director
3
Bernstein Bruce
Director
2
Chapman Christopher C Jr
OfficerDirector
2
Eagle Craig
Director
1

Showing 6-10 of 15

PrevPage 2 of 3Next

All filings

34 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue